Copyright Reports & Markets. All rights reserved.

Middle East and Africa Flow Cytometry Market Industry Trends Forecast to 2025

Buy now

TABLE OF CONTENTS

    1 INTRODUCTION

    • 1.1 OBJECTIVES OF THE STUDY
    • 1.2 MARKET DEFINITION
    • 1.3 OVERVIEW OF MIDDLE EAST & AFRICA FLOW CYTOMETRY MARKET
    • 1.4 CURRENCY AND PRICING
    • 1.5 LIMITATION
    • 1.6 MARKETS COVERED

    2 MARKET SEGMENTATION

    • 2.1 MARKETS COVERED
    • 2.2 YEARS CONSIDERED FOR THE STUDY
    • 2.3 CURRENCY AND PRICING
    • 2.4 RESEARCH METHODOLOGY
    • 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
    • 2.6 SECONDARY SOURCES
    • 2.7 ASSUMPTIONS

    3 EXECUTIVE SUMMARY

      4 PREMIUM INSIGHTS

        5 MIDDLE EAST & AFRICA FLOW CYTOMETRY MARKET, BY TECHNOLOGY

        • 5.1 OVERVIEW
        • 5.2 CELL-BASED FLOW CYTOMETRY
        • 5.3 BEAD-BASED FLOW CYTOMETRY

        6 MIDDLE EAST & AFRICA FLOW CYTOMETRY MARKET, BY PRODUCTS

        • 6.1 OVERVIEW
        • 6.2 REAGENTS AND CONSUMABLES
          • 6.2.1 ANTIBODIES
          • 6.2.2 DYES
          • 6.2.3 BEADS
          • 6.2.4 OTHERS
        • 6.3 FLOW CYTOMETRY INSTRUMENTS
          • 6.3.1 CELL ANALYZERS
          • 6.3.2 CELL SORTERS
        • 6.4 ACCESSORIES
          • 6.4.1 FILTERS
          • 6.4.2 LASER DEVICE
          • 6.4.3 DETECTORS
          • 6.4.4 OTHERS
        • 6.5 SERVICES

        7 MIDDLE EAST & AFRICA FLOW CYTOMETRY MARKET, BY APPLICATION

        • 7.1 OVERVIEW
        • 7.2 RESEARCH APPLICATIONS
          • 7.2.1 PHARMACEUTICAL AND BIOTECHNOLOGY
            • 7.2.1.1 DRUG DISCOVERY
            • 7.2.1.2 STEM CELL RESEARCH
            • 7.2.1.3 IN VITRO TOXICITY TESTING
          • 7.2.2 IMMUNOLOGY
          • 7.2.3 APOPTOSIS
          • 7.2.4 CELL SORTING/ SCREENING
          • 7.2.5 CELL CYCLE ANALYSIS
          • 7.2.6 CELL TRANSFECTION/VIABILITY
          • 7.2.7 CELL COUNTING
          • 7.2.8 OTHERS
        • 7.3 CLINICAL APPLICATIONS
          • 7.3.1 CANCER
          • 7.3.2 HEMATOLOGY
          • 7.3.3 IMMUNODEFICIENCY DISEASES
          • 7.3.4 ORGAN TRANSPLANTATION
          • 7.3.5 OTHER CLINICAL APPLICATIONS
        • 7.4 INDUSTRIAL APPLICATIONS

        8 MIDDLE EAST & AFRICA FLOW CYTOMETRY MARKET, BY END USER

        • 8.1 OVERVIEW
        • 8.2 ACADEMIC & RESEARCH INSTITUTES
        • 8.3 HOSPITALS
        • 8.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
        • 8.5 CLINICAL TESTING LABORATORIES
        • 8.6 BLOOD BANK
        • 8.7 OTHERS

        9 MIDDLE EAST & AFRICA FLOW CYTOMETRY MARKET, BY GEOGRAPHY

        • 9.1 OVERVIEW
        • 9.2 MIDDLE EAST AND AFRICA
          • 9.2.1 SOUTH AFRICA
          • 9.2.2 REST OF MIDDLE EAST & AFRICA
          • 9.2.3 EGYPT
          • 9.2.4 SAUDI ARABIA
          • 9.2.5 UNITED ARAB EMIRATES
          • 9.2.6 ISRAEL

        10 MIDDLE EAST & AFRICA FLOW CYTOMETRY MARKET, COMPANY LANDSCAPE

        • 10.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA

        11 COMPANY PROFILE

        • 11.1 BD.
          • 11.1.1 COMPANY OVERVIEW
          • 11.1.2 REVENUE ANALYSIS
          • 11.1.3 COMPANY SHARE ANAYLYSIS
          • 11.1.4 PRODUCT PORTFOLIO
          • 11.1.5 RECENT DEVELOPMENTS
        • 11.2 MERCK KGAA
          • 11.2.1 COMPANY OVERVIEW
          • 11.2.2 REVENUE ANALYSIS
          • 11.2.3 COMPANY SHARE ANAYLYSIS
          • 11.2.4 PRODUCT PORTFOLIO
          • 11.2.5 RECENT DEVELOPMENTS
        • 11.3 BIO-RAD LABORATORIES, INC.
          • 11.3.1 COMPANY OVERVIEW
          • 11.3.2 REVENUE ANALYSIS
          • 11.3.3 COMPANY SHARE ANAYLYSIS
          • 11.3.4 PRODUCT PORTFOLIO
          • 11.3.5 RECENT DEVELOPMENTS
        • 11.4 ACEA BIO
          • 11.4.1 COMPANY OVERVIEW
          • 11.4.2 GEOGRAPHICAL PRESENCE
          • 11.4.3 PRODUCT PORTFOLIO
          • 11.4.4 RECENT DEVELOPMENTS
        • 11.5 AGILENT TECHNOLOGIES
          • 11.5.1 COMPANY OVERVIEW
          • 11.5.2 REVENUE ANALYSIS
          • 11.5.3 PRODUCT PORTFOLIO
          • 11.5.4 RECENT DEVELOPMENTS
        • 11.6 APOGEE FLOW SYSTEMS LTD.
          • 11.6.1 COMPANY OVERVIEW
          • 11.6.2 PRODUCT PORFOLIO
        • 11.7 BECKMAN COULTER, INC.
          • 11.7.1 COMPANY OVERVIEW
          • 11.7.2 GEOGRAPHICAL PRESENCE
          • 11.7.3 PODUCT PORTFOLIO
          • 11.7.4 RECENT DEVELOPEMENTS
        • 11.8 BIOMÉRIEUX SA
          • 11.8.1 COMPANY OVERVIEW
          • 11.8.2 REVENUE ANALYSIS
          • 11.8.3 PRODUCT PORTFOLIO
          • 11.8.4 RECENT DEVELOPMENTS
        • 11.9 ENZO LIFE SCIENCES, INC.
          • 11.9.1 COMPANY OVERVIEW
          • 11.9.2 GEOGRAPHICAL PRESENCE
          • 11.9.3 PODUCT PORTFOLIO
          • 11.9.4 RECENT DEVELOPEMENTS
        • 11.10 LUMINEX CORPORATION.
          • 11.10.1 COMPANY OVERVIEW
          • 11.10.2 REVENUE ANALYSIS
          • 11.10.3 PRODUCT PORTFOLIO
          • 11.10.4 RECENT DEVELOPMENTS
        • 11.11 MECHATRONICS
          • 11.11.1 COMPANY OVERVIEW
          • 11.11.2 GEOGRAPHICAL PRESENCE
          • 11.11.3 PRODUCT PORTFOLIO
        • 11.12 MILTENYI BIOTEC
          • 11.12.1 COMPANY OVERVIEW
          • 11.12.2 GEOGRAPHICAL PRESENCE
          • 11.12.3 PRODUCT PORTFOLIO
          • 11.12.4 RECENT DEVELOPMENTS
        • 11.13 SONY BIOTECHNOLOGY INC.
          • 11.13.1 COMPANY OVERVIEW
          • 11.13.2 GEOGRAPHICAL PRESENCE
          • 11.13.3 PRODUCT PORTFOLIO
          • 11.13.4 RECENT DEVELOPMENTS
        • 11.14 STRATEDIGM, INC.
          • 11.14.1 COMPANY OVERVIEW
          • 11.14.2 PRODUCT PORTFOLIO
        • 11.15 SYSMEX PARTEC GMBH (A SUBSIDARY OF SYSMEX CORPORATION)
          • 11.15.1 COMPANY OVERVIEW
          • 11.15.2 GEOGRAPHICAL PRESENCE
          • 11.15.3 PRODUCT PORTFOLIO
          • 11.15.4 RECENT DEVELOPMENTS
        • 11.16 TAKARA BIO INC.
          • 11.16.1 COMPANY OVERVIEW
          • 11.16.2 REVENUE ANALYSIS
          • 11.16.3 PRODUCT PORTFOLIO
          • 11.16.4 RECENT DEVELOPMENTS
        • 11.17 THERMO FISHER SCIENTIFIC INC.
          • 11.17.1 COMPANY OVERVIEW
          • 11.17.2 REVENUE ANALYSIS
          • 11.17.3 PRODUCT PORTFOLIO
          • 11.17.4 RECENT DEVELOPMENTS

        12 RELATED REPORTS

        Middle East & Africa flow cytometry market is expected to reach a CAGR of 7.6% in the forecast period of 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
        Market Segmentation
        By Technology (Cell-Based Flow Cytometry, Bead-Based Flow Cytometry), Products (Reagents And Consumables, Flow Cytometry Instruments, Accessories, Services), Application (Research Applications, Clinical Application, Industrial Applications), End User (Academic & Research Institutes Pharmaceutical & Biotechnology Companies, Hospitals, Clinical Testing Laboratories, Blood Bank, Others), Country (South Africa and Rest of Middle East & Africa)

        Major growing sectors under the market segmentation are as follows:

        • In technology, cell based assay segment is dominating the market and bead based growing with the highest CAGR because Flow cytometry has wide research applications such as apoptosis, b-cell, bead-based immunoassays, cell and tissue microscopy, clinical, intracellular flow, multicolor flow, stem cell and t-cell immunology. These assays are differentiated by cell based screening and bead based screening whereas the advanced cell based assays includes real-time intracellular calcium response measurements and high-content fluorescent imaging systems whereas bead based screening involves micro beads which works as the solid matrix for antibodies or proteins. And the developments of the new technologies such as high-throughput (HT) flow cytometry are extending the capabilities of cell-based screening technologies.

        • In products, reagent and consumable is dominating the market and flow cytometry instruments are growing with the highest CAGR because various types of reagents are used for the flow cytometry application such as dyes, antibodies, beads and others. The antibodies are having wide application in fields of immunology, cancer and veterinary science. Other flow cytometry reagents include standards for fluorophores, cell types, and for instrument calibration. The dyes are extracted from live cells which make the process assessable for cell health and cell viability. Typically they work for the staining the nuclei of dead and live cells.

        • In Application, research application dominating the market and clinical application is growing with the highest CAGR because flow cytometry is used in the health research and treatment such as in the treatment of HIV infection, in case of treating leukemia and lymphoma patients not only limited to this but the technology has also have its wide usage to other application such as cross-matching organs for transplantation, apoptosis, research involving stem cells and others. In clinical applications, flow cytometer is used in various fields such as immunophenotyping of a variety of specimens, including whole blood, bone marrow, serous cavity fluids, cerebrospinal fluid, urine, and solid tissues leading the growth of the market.

        • In end user, academic & research institutes is dominating the market and growing with the highest CAGR due to flow cytometry the researchers are being assisted by various ways such as rapid examination of diverse individual cell types within a population of cells suspended in fluid. High-performance flow cytometers as well as high-speed cell sorters have their high usage in research such as HIV research, cancer, stem cell and drug discovery leading the growth of the market.

        Key Market Players

        The key market players for Middle East & Africa flow cytometry market are listed below:

        • Bio-Rad Laboratories, Inc.
        • Miltenyi Biotec Sysmex Partec GmbH
        • BIOMÉRIEUX
        • Mechatronics
        • Apogee Flow Systems Ltd.
        • Stratedigm, Inc.
        • Sony Biotechnology Inc.
        • BD.
        • Thermo Fisher Scientific Inc.
        • Merck KGaA
        • ACEA BIO
        • Agilent Technologies
        • Luminex Corporation.
        • Enzo Life Sciences, Inc.
        • Beckman Coulter, Inc.
        • Takara Bio Inc.

        Buy now